Session Details

F024 Pemphigus and Pemphigoid: Evidence-based Updates

Fri, Mar 8, 1:00 PM - 3:00 PM
Room 5B
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

In this session we will review real-world pearls for the diagnosis and treatment of pemphigus and pemphigoid with the goal of providing tips that are easy to implement into clinical practice. We will discuss new information regarding mechanisms of disease pathogenesis and how these mechanisms provide rationale for new therapies. We will review the efficacy and safety of both established and newer treatments based on current evidence. Finally, we will present challenging cases that provide important teaching points. At the end of this session the audience will be able to diagnose and treat pemphigus and pemphigoid patients more effectively and confidently.

LEARNING OBJECTIVES

1.

Describe relevant pathogenic mechanisms of pemphigus and pemphigoid.

2.

Diagnose pemphigus and pemphigoid more effectively.

3.

Develop treatment plans for pemphigus and pemphigoid with more confidence.

SCHEDULE

9:00 PM

Pemphigus: Evidence based updates and practical clinical pearls

Donna Culton, MD, PhD, FAAD

9:25 PM

Bullous (and nonbullous) pemphigoid: Evidence based updates and practical clinical pearls

Annette Czernik, MD, FAAD

9:50 PM

Your new secret weapon: The IPPF

Rebecca Strong, RN

10:05 PM

Challenging cases and lessons learned

Heather M Holahan, MD, FAAD

10:20 PM

Mucous membrane pemphigoid: Evidence based updates and practical clinical pearls

Brittney Schultz, MD, FAAD

10:45 PM

Q&A

SPEAKERS

Donna Culton, MD, PhD, FAAD

Donna Culton, MD, PhD, FAAD

Annette Czernik, MD, FAAD

Annette Czernik, MD, FAAD

Heather M Holahan, MD, FAAD

Heather M Holahan, MD, FAAD

Brittney Schultz, MD, FAAD

Brittney Schultz, MD, FAAD

Rebecca Strong, RN

Rebecca Strong, RN

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Donna Culton, MD, PhD, FAAD

arGEN-X – Consultant(Fees); Biogen – Investigator(Salary); BMS – Investigator(Salary); Cabaletta Bio – Investigator(Salary); Eli Lilly and Company – Investigator(Salary); iCell Gene Therapeutics – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(Salary); Janssen Global Services, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Salary); Principia Biopharma Inc – Investigator(Salary); Regeneron – Investigator(Salary); Sanofi – Investigator(Salary); Sanofi Genzyme – Consultant (1099 relationship)(Fees);

Annette Czernik, MD, FAAD

argenx – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria);

Heather M Holahan, MD, FAAD

Novartis – Independent Contractor(Fees);

Brittney Schultz, MD, FAAD

arGEN-X – Advisory Board(Honoraria); AstraZeneca – Investigator(No Compensation Received); Elorac, Inc. – Investigator(No Compensation Received);

Rebecca Strong, RN

International Pemphigus and Pemphigoid Foundation – Employee(Salary);